Assessing peripheral neuropathy

18th February 2021

It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Many individuals receiving chemotherapy are nervous about mentioning peripheral neuropathy, and often minimise its impact, as they are concerned that their treatment could be reduced or stopped.

GatewayC’s ‘Managing Physical Effects’ course reviews the common side effects of cancer treatments and aims to help in the identification and management of some specific short- and long-term side effects, including peripheral neuropathy. This course features an interactive video consultation which demonstrates how a GP might assess the seriousness of the peripheral neuropathy of a colorectal cancer patient.

Find out more:

  • Access GatewayC’s Managing Physical Effects course here
  • Read Macmillan’s resources on peripheral neuropathy here

LinkedIn | Twitter | Facebook

Latest from the Blog

Related Posts